BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 26387546)

  • 41. Characterizing the HER2/neu status and metastatic potential of breast cancer stem/progenitor cells.
    Pommier SJ; Quan GG; Christante D; Muller P; Newell AE; Olson SB; Diggs B; Muldoon L; Neuwelt E; Pommier RF
    Ann Surg Oncol; 2010 Feb; 17(2):613-23. PubMed ID: 19838757
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lentivirus-mediated shRNA targeting Nanog inhibits cell proliferation and attenuates cancer stem cell activities in breast cancer.
    Hu C; Xu L; Liang S; Zhang Z; Zhang Y; Zhang F
    J Drug Target; 2016; 24(5):422-32. PubMed ID: 26339994
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Vitamin D compounds reduce mammosphere formation and decrease expression of putative stem cell markers in breast cancer.
    Wahler J; So JY; Cheng LC; Maehr H; Uskokovic M; Suh N
    J Steroid Biochem Mol Biol; 2015 Apr; 148():148-55. PubMed ID: 25445919
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cancer stem cells markers CD44, CD24 and ALDH1 in breast cancer special histological types.
    de Beça FF; Caetano P; Gerhard R; Alvarenga CA; Gomes M; Paredes J; Schmitt F
    J Clin Pathol; 2013 Mar; 66(3):187-91. PubMed ID: 23112116
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immunohistochemical detection of breast cancer stem cells in hormone receptor-positive breast cancer and their role in response to endocrine therapy and clinical outcome.
    Hashimoto K; Shimizu C; Tsuda H; Saji S; Osaki A; Shigekawa T; Aogi K
    Oncology; 2012; 82(3):168-74. PubMed ID: 22433454
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Overexpression of OCT4 induced by modulation of histone marks plays crucial role in breast cancer progression.
    Kar S; Patra SK
    Gene; 2018 Feb; 643():35-45. PubMed ID: 29203199
    [TBL] [Abstract][Full Text] [Related]  

  • 47. SOX2 expression is associated with a cancer stem cell state and down-regulation of CDX2 in colorectal cancer.
    Lundberg IV; Edin S; Eklöf V; Öberg Å; Palmqvist R; Wikberg ML
    BMC Cancer; 2016 Jul; 16():471. PubMed ID: 27411517
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Salinomycin Promotes Anoikis and Decreases the CD44+/CD24- Stem-Like Population via Inhibition of STAT3 Activation in MDA-MB-231 Cells.
    An H; Kim JY; Oh E; Lee N; Cho Y; Seo JH
    PLoS One; 2015; 10(11):e0141919. PubMed ID: 26528725
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Most early disseminated cancer cells detected in bone marrow of breast cancer patients have a putative breast cancer stem cell phenotype.
    Balic M; Lin H; Young L; Hawes D; Giuliano A; McNamara G; Datar RH; Cote RJ
    Clin Cancer Res; 2006 Oct; 12(19):5615-21. PubMed ID: 17020963
    [TBL] [Abstract][Full Text] [Related]  

  • 50. An adult tissue-specific stem cell molecular phenotype is activated in epithelial cancer stem cells and correlated to patient outcome.
    Hussenet T; Dembélé D; Martinet N; Vignaud JM; du Manoir S
    Cell Cycle; 2010 Jan; 9(2):321-7. PubMed ID: 20023397
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tumor suppression by Spinophilin.
    Santamaría D; Malumbres M
    Cell Cycle; 2011 Sep; 10(17):2831-2. PubMed ID: 21869595
    [No Abstract]   [Full Text] [Related]  

  • 52. Loss of MYBBP1A Induces Cancer Stem Cell Activity in Renal Cancer.
    Felipe-Abrio B; Verdugo-Sivianes EM; Sáez C; Carnero A
    Cancers (Basel); 2019 Feb; 11(2):. PubMed ID: 30781655
    [TBL] [Abstract][Full Text] [Related]  

  • 53. New role for Spinophilin in tumor suppression.
    Palmero I
    Cell Cycle; 2011 Oct; 10(20):3427. PubMed ID: 22024930
    [No Abstract]   [Full Text] [Related]  

  • 54. SPN: A year in review 2021.
    Northington LK
    J Pediatr Nurs; 2022; 62():200-201. PubMed ID: 35125169
    [No Abstract]   [Full Text] [Related]  

  • 55. The prognostic role of cancer stem cells in breast tumors.
    Bonito MD; Cantile M; Malzone G; Liguori G; Botti G
    J Clin Med Res; 2013 Oct; 5(5):325-6. PubMed ID: 23976904
    [No Abstract]   [Full Text] [Related]  

  • 56. SLUG is required for SOX9 stabilization and functions to promote cancer stem cells and metastasis in human lung carcinoma.
    Luanpitpong S; Li J; Manke A; Brundage K; Ellis E; McLaughlin SL; Angsutararux P; Chanthra N; Voronkova M; Chen YC; Wang L; Chanvorachote P; Pei M; Issaragrisil S; Rojanasakul Y
    Oncogene; 2016 Jun; 35(22):2824-33. PubMed ID: 26387547
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Single-cell analysis reveals a stem-cell program in human metastatic breast cancer cells.
    Lawson DA; Bhakta NR; Kessenbrock K; Prummel KD; Yu Y; Takai K; Zhou A; Eyob H; Balakrishnan S; Wang CY; Yaswen P; Goga A; Werb Z
    Nature; 2015 Oct; 526(7571):131-5. PubMed ID: 26416748
    [TBL] [Abstract][Full Text] [Related]  

  • 58. High mitochondrial mass identifies a sub-population of stem-like cancer cells that are chemo-resistant.
    Farnie G; Sotgia F; Lisanti MP
    Oncotarget; 2015 Oct; 6(31):30472-86. PubMed ID: 26421710
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Curcumin suppresses stem-like traits of lung cancer cells via inhibiting the JAK2/STAT3 signaling pathway.
    Wu L; Guo L; Liang Y; Liu X; Jiang L; Wang L
    Oncol Rep; 2015 Dec; 34(6):3311-7. PubMed ID: 26397387
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Regulation of the breast cancer stem cell phenotype by hypoxia-inducible factors.
    Semenza GL
    Clin Sci (Lond); 2015 Dec; 129(12):1037-45. PubMed ID: 26405042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.